Clinical Trials Browser

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

Sarcoma, Ewing

Prostatic Neoplasms

Meningioma, Central Nervous System Neoplasms

Advanced Malignant Solid Neoplasm

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Neoplasms, Thyroid Diseases

Carcinoma, Renal Cell

Leiomyosarcoma, Sarcoma

Prostatic Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Transitional Cell

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Neoplasm Metastasis

Neoplasm Metastasis, Colorectal Neoplasms

Osteosarcoma

Neuroendocrine Tumors

Brain Neoplasms, Carcinoma, Renal Cell

Neuroendocrine Tumors

High Grade Neuroendocrine Neoplasms

Pancreatic Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neurofibromatosis 1, Neurofibroma, Plexiform

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Adrenal Cortex Neoplasms, Adrenocortical Carcinoma

Carcinoma, Renal Cell

Squamous Cell Carcinoma of Head and Neck

Neoplasm Metastasis

Adenocarcinoma Of Esophagus, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms

Carcinoma, Renal Cell

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal, Seminoma

Breast Neoplasms, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Endometrial Neoplasms

Carcinoma, Renal Cell, Urologic Neoplasms

Metastatic Squamous Non-Small Cell Lung Carcinoma

Glioblastoma, Gliosarcoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular, Recurrence

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

Brain Neoplasms, Carcinoma, Renal Cell

Recurrence, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Metastatic Hormone Refractory Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Carcinoma, Renal Cell

Sarcoma, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

Clinical Trials

Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

METTSEO

AtezoCab

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

SAMURAI

CABOTHYROID

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

MegaMOST

Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Cabozantinib in High Grade Neuroendocrine Neoplasms

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

NF113

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

SKIPPY 2

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

CANOPY

CAMILLA

Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

LUNG-IST-127

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Cabozantinib and Pembrolizumab in Metastatic Pancreas

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

CaboLu

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

PEMBROCABOSARC